Adler & Manson Newsletter
ATTORNEYS AT LAW
816.333.0400
toll free 877.336.0400
adlerandmanson.com

March 1, 2009

In this issue:

Contact Us:
jim@adlerandmanson.com
bill@adlerandmanson.com
816.333.0400
Toll Free: 877.336.0400

 

 

 

Please enjoy these articles. Click on the title to read the entire article.

Please feel free to forward these to your friends. Also, please remember to keep us in mind should you have a friend in need of legal counsel with an injury claim.

In this issue:

Government: Drug Maker Illegally Marketed Antidepressant

Drug maker Forest Laboratories illegally marketed the antidepressant Celexa to children and teens, costing the government millions of dollars, according to a Department of Justice complaint filed Wednesday. The Department of Justice says the New York-based company hid the results of a clinical trial that showed the drug to be ineffective and possibly dangerous for use by children. Additionally, the agency accuses Forest of paying kickbacks to doctors who prescribed Celexa and other drugs.  Barry Meier and Benedict Carey, The New York Times 02/25/2009

Researchers Push for More Clarity on Drug Risks

Medical school researchers are pushing federal regulators to force drug companies to disclose the benefits of their drugs in much the same way that food companies list nutrition facts on packaging. The Dartmouth University doctors say that drug advertising should quantify the benefits of taking a drug compared with a placebo and list the odds of having side effects. The proposal, scheduled to be delivered to the Food and Drug Administration, is based on research published in the Annals of Internal Medicine.  Natasha Singer, The New York Times 02/25/2009

Study Raises New Concerns About Heart Device

A new study says that electrical cables widely used in implanted defibrillators may be failing more often than previously thought. The study, which focuses on Medtronic’s Sprint Fidelis lead, found that fewer leads were still functioning than reported by the device maker and that the failure rate may get worse over time. Two years ago, Medtronic recalled thousands of Sprint Fidelis leads after discovering a potentially life threatening malfunction.  Barry Meier, The New York Times 02/23/2009

Wal-Mart Settles Racial Bias Lawsuit

Retail giant Wal-Mart has agreed to pay $17.5 million to settle a class-action lawsuit accusing the company of racial bias. According to the lawsuit, Wal-Mart discriminated against African-American truck driving applicants. Under the settlement, Wal-Mart has also agreed to hire additional black applicants and pursue other diversity initiatives. The case is Nelson v. Wal-Mart Stores Inc.  Margaret Cronin Fisk, Bloomberg 02/20/2009

Study Questions Overseas Clinical Trials

The outsourcing of clinical trials to developing nations may present ethical and practice concerns for drugs intended to be used in the United States, an article published in the New England Journal of Medicine has concluded. According to several Duke University researchers, foreign research participants could be unduly biased by financial or healthcare incentives associated with taking part in medical researchers. Equally, the authors suggest that results yielded from some foreign populations may not be applicable to American patients.  Natasha Singer, The New York Times 02/18/2009

Advocates Warn of Rise in Job Scams

In the current ailing economy, consumer advocates are warning job seekers to be wary of scams promising the perfect job for a price. According20to the Consumer Protection Agency, 6,000 people filed complaints about headhunters and employment and placement agencies during 2007. In response, state and federal authorities are taking action against firms seeking to profit nefariously from people’s unemployment.  Steve Giegerich, St. Louis Post Dispatch 02/17/2009

To stop receiving these emails please click here.

Adler & Manson
9233 Ward Parkway, Suite 240
Kansas City, Missouri 64114
816.333.0400
toll free 877.336.0400